We are live on ! Find out more
BTW

Boston Trust Walden Portfolio holdings

AUM $13.1B
1-Year Est. Return 24.63%
This Fund
S&P 500
This Quarter Est. Return
-5.84%
1 Year Est. Return
+24.63%
3 Year Est. Return
+61.41%
5 Year Est. Return
+82.17%
10 Year Est. Return
+348.28%
AUM
$5.99B
AUM Growth
-$571M
Cap. Flow
-$107M
Cap. Flow %
-1.78%
Top 10 Hldgs %
12.64%
Holding
363
New
17
Increased
100
Reduced
214
Closed
10

Sector Composition

Rank Sector Weight
1 Financials 17.98%
2 Technology 15.56%
3 Healthcare 15.35%
4 Industrials 12.45%
5 Consumer Discretionary 11.16%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
HSIC icon
351
Henry Schein
HSIC
$9.78B
$226K ﹤0.01%
4,335
ETN icon
352
Eaton
ETN
$140B
$221K ﹤0.01%
4,304
+754
+21% +$44.5K
UL icon
353
Unilever
UL
$142B
$203K ﹤0.01%
+4,422
New +$211K
EFA icon
354
iShares MSCI EAFE ETF
EFA
$76.6B
-8,263
Closed -$525K
NVO
355
Novo Nordisk
NVO
$228B
-9,700
Closed -$266K
WBD icon
356
Warner Bros
WBD
$64.2B
-6,231
Closed -$207K
AGN
357
DELISTED
Allergan plc
AGN
-686
Closed -$208K
MLNX
358
DELISTED
Mellanox Technologies, Ltd.
MLNX
-205,757
Closed -$10M
IPCM
359
DELISTED
IPC HEALTHCARE INC COM DTD
IPCM
-432,835
Closed -$24M
THOR
360
DELISTED
THORATEC CORPORATION
THOR
-619,046
Closed -$27.6M
BRLI
361
DELISTED
BIO-REFERENCE LABS INC-NEW-
BRLI
-959,914
Closed -$39.6M
DTV
362
DELISTED
DIRECTV COM STK (DE)
DTV
-279,801
Closed -$26M
GAS
363
DELISTED
AGL Resources Inc
GAS
-103,264
Closed -$4.81M

Similar funds

Boston Trust Walden's Q3 2015 Portfolio in Review

As of Q3 2015, Boston Trust Walden held 363 positions worth $5.99B, down 8.7% from $6.56B the previous quarter. Its ten largest holdings account for 13% of the portfolio.

Boston Trust Walden's Q3 2015 filing shows 17 new, 100 increased, 214 reduced and 10 closed positions. Its largest new stake was Accendra Health: 954,271 shares worth $30.5M. The largest sale was BIO-REFERENCE LABS INC-NEW-, an estimated $39.6M.

By sector, the portfolio is most concentrated in Financials at 18% of assets, up from 18% a quarter earlier, followed by Technology and Healthcare.

  • Boston Trust Walden's largest Q3 2015 buy was Accendra Health: 954,271 shares worth $30.5M.
  • Boston Trust Walden added most to Oceaneering in Q3 2015, an estimated $14.8M increase.
  • Boston Trust Walden's biggest Q3 2015 reduction was Alphabet (Google) Class C, cutting an estimated $19.1M.
  • Boston Trust Walden fully exited BIO-REFERENCE LABS INC-NEW- in Q3 2015, selling an estimated $39.6M.
  • Boston Trust Walden's ten largest holdings make up 13% of its $5.99B portfolio in Q3 2015.
  • Boston Trust Walden opened 17 new positions and closed 10 in Q3 2015.
  • Boston Trust Walden's portfolio value fell 8.7% quarter-over-quarter to $5.99B.

Based on Boston Trust Walden's 13F filing for Q3 2015, filed 29 Oct 2015.